1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Diagnostic Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Infectious Testing
1.2.3 Diabetes Testing
1.2.4 Molecular Testing
1.2.5 Tissue Testing
1.3 Market by Application
1.3.1 Global In-vitro Diagnostic Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Point-Of-Care Testing
1.3.4 Laboratories
1.3.5 Academic Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Diagnostic Services Market Perspective (2017-2028)
2.2 In-vitro Diagnostic Services Growth Trends by Region
2.2.1 In-vitro Diagnostic Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 In-vitro Diagnostic Services Historic Market Size by Region (2017-2022)
2.2.3 In-vitro Diagnostic Services Forecasted Market Size by Region (2023-2028)
2.3 In-vitro Diagnostic Services Market Dynamics
2.3.1 In-vitro Diagnostic Services Industry Trends
2.3.2 In-vitro Diagnostic Services Market Drivers
2.3.3 In-vitro Diagnostic Services Market Challenges
2.3.4 In-vitro Diagnostic Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Diagnostic Services Players by Revenue
3.1.1 Global Top In-vitro Diagnostic Services Players by Revenue (2017-2022)
3.1.2 Global In-vitro Diagnostic Services Revenue Market Share by Players (2017-2022)
3.2 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-vitro Diagnostic Services Revenue
3.4 Global In-vitro Diagnostic Services Market Concentration Ratio
3.4.1 Global In-vitro Diagnostic Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostic Services Revenue in 2021
3.5 In-vitro Diagnostic Services Key Players Head office and Area Served
3.6 Key Players In-vitro Diagnostic Services Product Solution and Service
3.7 Date of Enter into In-vitro Diagnostic Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Diagnostic Services Breakdown Data by Type
4.1 Global In-vitro Diagnostic Services Historic Market Size by Type (2017-2022)
4.2 Global In-vitro Diagnostic Services Forecasted Market Size by Type (2023-2028)
5 In-vitro Diagnostic Services Breakdown Data by Application
5.1 Global In-vitro Diagnostic Services Historic Market Size by Application (2017-2022)
5.2 Global In-vitro Diagnostic Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In-vitro Diagnostic Services Market Size (2017-2028)
6.2 North America In-vitro Diagnostic Services Market Size by Country (2017-2022)
6.3 North America In-vitro Diagnostic Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe In-vitro Diagnostic Services Market Size (2017-2028)
7.2 Europe In-vitro Diagnostic Services Market Size by Country (2017-2022)
7.3 Europe In-vitro Diagnostic Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Diagnostic Services Market Size (2017-2028)
8.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Country (2017-2022)
8.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America In-vitro Diagnostic Services Market Size (2017-2028)
9.2 Latin America In-vitro Diagnostic Services Market Size by Country (2017-2022)
9.3 Latin America In-vitro Diagnostic Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Diagnostic Services Market Size (2017-2028)
10.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2017-2022)
10.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 BioRad
11.1.1 BioRad Company Detail
11.1.2 BioRad Business Overview
11.1.3 BioRad In-vitro Diagnostic Services Introduction
11.1.4 BioRad Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.1.5 BioRad Recent Development
11.2 DexCom
11.2.1 DexCom Company Detail
11.2.2 DexCom Business Overview
11.2.3 DexCom In-vitro Diagnostic Services Introduction
11.2.4 DexCom Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.2.5 DexCom Recent Development
11.3 Nova Biomedical
11.3.1 Nova Biomedical Company Detail
11.3.2 Nova Biomedical Business Overview
11.3.3 Nova Biomedical In-vitro Diagnostic Services Introduction
11.3.4 Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.3.5 Nova Biomedical Recent Development
11.4 OraSure
11.4.1 OraSure Company Detail
11.4.2 OraSure Business Overview
11.4.3 OraSure In-vitro Diagnostic Services Introduction
11.4.4 OraSure Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.4.5 OraSure Recent Development
11.5 Pearl Pathways
11.5.1 Pearl Pathways Company Detail
11.5.2 Pearl Pathways Business Overview
11.5.3 Pearl Pathways In-vitro Diagnostic Services Introduction
11.5.4 Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.5.5 Pearl Pathways Recent Development
11.6 Phenomenex
11.6.1 Phenomenex Company Detail
11.6.2 Phenomenex Business Overview
11.6.3 Phenomenex In-vitro Diagnostic Services Introduction
11.6.4 Phenomenex Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.6.5 Phenomenex Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen In-vitro Diagnostic Services Introduction
11.7.4 Qiagen Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.7.5 Qiagen Recent Development
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Company Detail
11.8.2 Roche Diagnostics Business Overview
11.8.3 Roche Diagnostics In-vitro Diagnostic Services Introduction
11.8.4 Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.8.5 Roche Diagnostics Recent Development
11.9 Siemens
11.9.1 Siemens Company Detail
11.9.2 Siemens Business Overview
11.9.3 Siemens In-vitro Diagnostic Services Introduction
11.9.4 Siemens Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.9.5 Siemens Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Detail
11.10.2 Sysmex Business Overview
11.10.3 Sysmex In-vitro Diagnostic Services Introduction
11.10.4 Sysmex Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.10.5 Sysmex Recent Development
11.11 Thermofisher
11.11.1 Thermofisher Company Detail
11.11.2 Thermofisher Business Overview
11.11.3 Thermofisher In-vitro Diagnostic Services Introduction
11.11.4 Thermofisher Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.11.5 Thermofisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global In-vitro Diagnostic Services Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Infectious Testing
Table 3. Key Players of Diabetes Testing
Table 4. Key Players of Molecular Testing
Table 5. Key Players of Tissue Testing
Table 6. Global In-vitro Diagnostic Services Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global In-vitro Diagnostic Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global In-vitro Diagnostic Services Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global In-vitro Diagnostic Services Market Share by Region (2017-2022)
Table 10. Global In-vitro Diagnostic Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global In-vitro Diagnostic Services Market Share by Region (2023-2028)
Table 12. In-vitro Diagnostic Services Market Trends
Table 13. In-vitro Diagnostic Services Market Drivers
Table 14. In-vitro Diagnostic Services Market Challenges
Table 15. In-vitro Diagnostic Services Market Restraints
Table 16. Global In-vitro Diagnostic Services Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global In-vitro Diagnostic Services Market Share by Players (2017-2022)
Table 18. Global Top In-vitro Diagnostic Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Diagnostic Services as of 2021)
Table 19. Ranking of Global Top In-vitro Diagnostic Services Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by In-vitro Diagnostic Services Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players In-vitro Diagnostic Services Product Solution and Service
Table 23. Date of Enter into In-vitro Diagnostic Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global In-vitro Diagnostic Services Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global In-vitro Diagnostic Services Revenue Market Share by Type (2017-2022)
Table 27. Global In-vitro Diagnostic Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global In-vitro Diagnostic Services Revenue Market Share by Type (2023-2028)
Table 29. Global In-vitro Diagnostic Services Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global In-vitro Diagnostic Services Revenue Market Share by Application (2017-2022)
Table 31. Global In-vitro Diagnostic Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global In-vitro Diagnostic Services Revenue Market Share by Application (2023-2028)
Table 33. North America In-vitro Diagnostic Services Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America In-vitro Diagnostic Services Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe In-vitro Diagnostic Services Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe In-vitro Diagnostic Services Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America In-vitro Diagnostic Services Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America In-vitro Diagnostic Services Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2023-2028) & (US$ Million)
Table 43. BioRad Company Detail
Table 44. BioRad Business Overview
Table 45. BioRad In-vitro Diagnostic Services Product
Table 46. BioRad Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 47. BioRad Recent Development
Table 48. DexCom Company Detail
Table 49. DexCom Business Overview
Table 50. DexCom In-vitro Diagnostic Services Product
Table 51. DexCom Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 52. DexCom Recent Development
Table 53. Nova Biomedical Company Detail
Table 54. Nova Biomedical Business Overview
Table 55. Nova Biomedical In-vitro Diagnostic Services Product
Table 56. Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 57. Nova Biomedical Recent Development
Table 58. OraSure Company Detail
Table 59. OraSure Business Overview
Table 60. OraSure In-vitro Diagnostic Services Product
Table 61. OraSure Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 62. OraSure Recent Development
Table 63. Pearl Pathways Company Detail
Table 64. Pearl Pathways Business Overview
Table 65. Pearl Pathways In-vitro Diagnostic Services Product
Table 66. Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 67. Pearl Pathways Recent Development
Table 68. Phenomenex Company Detail
Table 69. Phenomenex Business Overview
Table 70. Phenomenex In-vitro Diagnostic Services Product
Table 71. Phenomenex Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 72. Phenomenex Recent Development
Table 73. Qiagen Company Detail
Table 74. Qiagen Business Overview
Table 75. Qiagen In-vitro Diagnostic Services Product
Table 76. Qiagen Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 77. Qiagen Recent Development
Table 78. Roche Diagnostics Company Detail
Table 79. Roche Diagnostics Business Overview
Table 80. Roche Diagnostics In-vitro Diagnostic Services Product
Table 81. Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 82. Roche Diagnostics Recent Development
Table 83. Siemens Company Detail
Table 84. Siemens Business Overview
Table 85. Siemens In-vitro Diagnostic Services Product
Table 86. Siemens Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 87. Siemens Recent Development
Table 88. Sysmex Company Detail
Table 89. Sysmex Business Overview
Table 90. Sysmex In-vitro Diagnostic Services Product
Table 91. Sysmex Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 92. Sysmex Recent Development
Table 93. Thermofisher Company Detail
Table 94. Thermofisher Business Overview
Table 95. Thermofisher In-vitro Diagnostic ServicesProduct
Table 96. Thermofisher Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million)
Table 97. Thermofisher Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-vitro Diagnostic Services Market Share by Type: 2021 VS 2028
Figure 2. Infectious Testing Features
Figure 3. Diabetes Testing Features
Figure 4. Molecular Testing Features
Figure 5. Tissue Testing Features
Figure 6. Global In-vitro Diagnostic Services Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. Point-Of-Care Testing Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Academic Institutes Case Studies
Figure 11. In-vitro Diagnostic Services Report Years Considered
Figure 12. Global In-vitro Diagnostic Services Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global In-vitro Diagnostic Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global In-vitro Diagnostic Services Market Share by Region: 2021 VS 2028
Figure 15. Global In-vitro Diagnostic Services Market Share by Players in 2021
Figure 16. Global Top In-vitro Diagnostic Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Diagnostic Services as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by In-vitro Diagnostic Services Revenue in 2021
Figure 18. North America In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America In-vitro Diagnostic Services Market Share by Country (2017-2028)
Figure 20. United States In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe In-vitro Diagnostic Services Market Share by Country (2017-2028)
Figure 24. Germany In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific In-vitro Diagnostic Services Market Share by Region (2017-2028)
Figure 32. China In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America In-vitro Diagnostic Services Market Share by Country (2017-2028)
Figure 40. Mexico In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa In-vitro Diagnostic Services Market Share by Country (2017-2028)
Figure 44. Turkey In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia In-vitro Diagnostic Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. BioRad Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 47. DexCom Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 48. Nova Biomedical Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 49. OraSure Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 50. Pearl Pathways Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 51. Phenomenex Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 52. Qiagen Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 53. Roche Diagnostics Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 54. Siemens Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 55. Sysmex Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 56. Thermofisher Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BioRad DexCom Nova Biomedical OraSure Pearl Pathways Phenomenex Qiagen Roche Diagnostics Siemens Sysmex Thermofisher